Candidate psychotropics against SARS–CoV–2: A narrative review
M Khosravi - Pharmacopsychiatry, 2022 - thieme-connect.com
Since few therapeutic options are clinically accessible for coronavirus disease 2019 (COVID-
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
Candidate Psychotropics against SARS-CoV-2: A Narrative Review.
M Khosravi - Pharmacopsychiatry, 2021 - europepmc.org
Since few therapeutic options are clinically accessible for coronavirus disease 2019 (COVID-
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
Candidate Psychotropics against SARS-CoV-2: A Narrative Review
M Khosravi - Pharmacopsychiatry, 2022 - pubmed.ncbi.nlm.nih.gov
Since few therapeutic options are clinically accessible for coronavirus disease 2019 (COVID-
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
Candidate Psychotropics against SARS–CoV–2: A Narrative Review
M Khosravi - Pharmacopsychiatry, 2021 - thieme-connect.com
Since few therapeutic options are clinically accessible for coronavirus disease 2019 (COVID-
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …